Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Patients were almost there

Then the best thing they can do is recognize that they need to introduce into their ranks professional leaders who understand the technology market, development of shareholder value, and what it means to provide strategic and operational leadership. What happens at real companies is that the BOD level often takes the hit as much as the C-level leadership. I've never seen so much C-level housecleaning without there being some level of BOD impact.

The present BOD of directors need to refresh their own ranks. How to float shares vote in the annual BOD elections? Do they vote as the company recommends? If so, this is a dead stock until the majority of shares are out of the control of the BOD.

Share
New Message
Please login to post a reply